Workflow
Radian(RDN)
icon
搜索文档
Radian: Attractive With Solid Results And Transformative M&A (NYSE:RDN)
Seeking Alpha· 2025-11-06 06:11
Shares of Radian Group ( RDN ) have been a moderate performer over the past year, gaining about 5%. We have seen shares pull back about 9% from their recent highs in September, following the announcement of a transformative acquisition, amid increasing concerns about the trajectoryOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have ...
Radian: Attractive With Solid Results And Transformative M&A
Seeking Alpha· 2025-11-06 06:11
Shares of Radian Group ( RDN ) have been a moderate performer over the past year, gaining about 5%. We have seen shares pull back about 9% from their recent highs in September, following the announcement of a transformative acquisition, amid increasing concerns about the trajectoryOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have ...
Radian(RDN) - 2025 Q3 - Earnings Call Transcript
2025-11-06 01:02
Radian Group (NYSE:RDN) Q3 2025 Earnings Call November 05, 2025 11:00 AM ET Company ParticipantsRick Thornberry - CEOSumita Pandit - President and CFODan Kobell - EVP of FinanceConference Call ParticipantsBose George - AnalystDoug Harter - AnalystMihir Bhatia - AnalystSumita PanditToday, and thank you for standing by. Welcome to the third quarter 2025 Radian Group conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer ...
Radian(RDN) - 2025 Q3 - Earnings Call Transcript
2025-11-06 01:00
Radian Group (NYSE:RDN) Q3 2025 Earnings Call November 05, 2025 11:00 AM ET Speaker3Today, and thank you for standing by. Welcome to the third quarter 2025 Radian Group conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press Star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, plea ...
Radian(RDN) - 2025 Q3 - Earnings Call Presentation
2025-11-06 00:00
Financial Results Q3 2025 NYSE: RDN www.radian.com Safe Harbor Statements All statements in this presentation that address events, developments or results that we expect or anticipate may occur in the future are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the U.S. Private Securities Litigation Reform Act of 1995. In most cases, forward- looking statements may be identified by words such as "anticipate," ...
Radian(RDN) - 2025 Q3 - Quarterly Results
2025-11-05 21:00
Exhibit 99.1 press release November 4, 2025 Radian Announces Third Quarter 2025 Financial Results — Company on track to acquire Inigo, a highly profitable Lloyd's specialty insurer, for $1.7 billion — — Following a comprehensive strategic review, announced divestiture plan for Mortgage Conduit, Title and Real Estate Services businesses — — Inigo acquisition, along with divestitures, set to transform Radian into global multi-line specialty insurer — — Third quarter net income from continuing operations of $1 ...
Radian (RDN) Tops Q3 Earnings Estimates
ZACKS· 2025-11-05 09:01
Radian (RDN) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $1.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +21.05%. A quarter ago, it was expected that this mortgage insurer would post earnings of $0.93 per share when it actually produced earnings of $1.01, delivering a surprise of +8.6%.Over the last four quarters, the company h ...
Radian Announces Third Quarter 2025 Financial Results
Businesswire· 2025-11-05 06:17
WAYNE, Pa.--(BUSINESS WIRE)--Radian Group Inc. (NYSE: RDN) today reported diluted net income from continuing operations for the quarter ended September 30, 2025, of $153 million, or $1.11 per share. This compares with diluted net income from continuing operations for the quarter ended September 30, 2024, of $167 million, or $1.09 per share. Pretax income from continuing operations for the quarter ended September 30, 2025, was $199 million compared to $214 million for the quarter ended September. ...
UBS Cuts Radian Group (RDN) Price Target to $40; Company Announces $1.7 Billion Inigo Acquisition
Yahoo Finance· 2025-10-31 07:06
Radian Group Inc. (NYSE:RDN) is included among the 15 Dividend Growth Stocks with the Highest Growth Rates. UBS Cuts Radian Group (RDN) Price Target to $40; Company Announces $1.7 Billion Inigo Acquisition Photo by Vitaly Taranov on Unsplash Radian Group Inc. (NYSE:RDN) operates as a holding company o⁠ffering m‌ortgage in‍surance, risk management p⁠rodu‍c​ts, and real estate ser⁠v‌ices to fina⁠ncia​l institutions.‌ On October 15, UB⁠S reduced i‍ts price targe‍t for Radian Group Inc. (NYSE:RDN) from $43 ...
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
Prnewswire· 2025-10-29 06:36
核心观点 - 美国医疗保险和医疗补助服务中心(CMS)发布了关于肾脏去神经术(RDN)的最终国家覆盖决定(NCD),适用于美敦力公司的Symplicity Spyral RDN系统,这将使符合条件的Medicare患者能够获得该疗法,用于治疗未受控制的高血压[1] 医保覆盖与市场准入 - 最终的国家覆盖决定为Medicare患者提供了使用Symplicity血压治疗程序的机会,以治疗未受控制的高血压[1] - 该决定为美敦力开辟了一个新颖且重要的市场,将其肾脏去神经技术定位为公司最令人兴奋的增长动力之一[1] - Symplicity Spyral系统已在美国主要中心提供,包括大型综合医疗网络,作为其高血压护理服务的一部分[1] 产品技术与临床数据 - Symplicity Spyral RDN系统是一种创新的微创手术,通过向肾脏附近可能过度活跃并导致高血压的神经输送射频能量来发挥作用[1] - 该系统于2023年11月获得美国食品药品监督管理局(FDA)批准[1] - 美敦力SPYRAL HTN全球临床项目是最全面的RDN临床研究项目,涉及超过5,000名患者,并得到全球超过30,000名患者经验的支持[3] - Symplicity Spyral RDN系统在随机对照和真实世界登记试验中已证明可持续降压长达三年[3] - Symplicity Spyral是唯一具有广泛、持久、一致、长期数据和单一导管设计的商用RDN设备[3] 高血压疾病负担 - 高血压是一种全球健康危机,是心脏病发作、中风和死亡的主要可改变原因[2] - 尽管有药物和生活方式改变等可用治疗方法,但许多患者的血压仍未得到控制,近80%的高血压成人患者病情未受控制,50%的高血压患者在一年内变得不坚持服药[2] 公司战略与影响 - 这一里程碑使医生在管理高血压时能为患者提供更多选择,可能为急需新选择的人群带来更好的结果[1] - 公司的商业团队将积极利用这一里程碑,与医疗保健提供者和高血压中心密切合作,以加速这一变革性增长机会的采用[1] - Symplicity Spyral RDN系统已在全球近80个国家获准商用[2]